Palmitoylation: policing protein stability and traffic
Unlike older peptides such as GHRP-6 or GHRP-2 , ipamorelin does not significantly raise cortisol or prolactin levels
Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
If you were to treat 100,000 people with these drugs, over a lifetime youd have a dramatic reduction in obesity
If you take oral semaglutide or tirzepatide, these are absorbed best on an empty or near-empty stomach, making early morning doses before your eating window practical
Multi-Pathway Metabolic Correction (Future) Bioglutide The four-receptor mechanism (GLP-1/GIP/glucagon/IGF-1) is the broadest metabolic coverage of any obesity agent in development, theoretically providing more comprehensive metabolic improvement than single-target agents